AI may help predict responses to non-small cell lung cancer systemic therapies

Bottom Line: Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers utilized artificial intelligence (AI) to train algorithms to predict tumor sensitivity to three systemic cancer therapies. Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research Author: Laurent…